Vasodilator myocardial perfusion cardiac magnetic resonance imaging is superior to dobutamine stress echocardiography in the detection of relevant coronary artery Stenosis: a systematic review and meta-analysis on their diagnostic accuracy

Haberkorn, Sebastian M., Haberkorn, Sandra I., Bönner, Florian, Kelm, Malte, Hopkin, Gareth and Petersen, Steffen E. (2021) Vasodilator myocardial perfusion cardiac magnetic resonance imaging is superior to dobutamine stress echocardiography in the detection of relevant coronary artery Stenosis: a systematic review and meta-analysis on their diagnostic accuracy. Frontiers in Cardiovascular Medicine, 8. ISSN 2297-055X

Text (fcvm-08-630846) - Published Version Available under License Creative Commons Attribution. Download (2MB)

Abstract

Objectives: Guideline recommendations for patients with either a high or a low risk of obstructive coronary artery disease (CAD) are clear. However, the evidence for initial risk stratification in patients with an intermediate risk of CAD is still unclear, despite the availability of multiple non-invasive assessment strategies. The aim of this study was to synthesize the evidence for this population to provide more informed recommendations. Background: A meta-analysis was performed to systematically assess the diagnostic accuracy of vasodilator myocardial perfusion cardiovascular magnetic resonance imaging (pCMR) and dobutamine stress echocardiography (DSE) for the detection of relevant CAD. In contrast to previous work, this meta-analysis follows rigorous selection criteria in regards to the risk stratification and a narrowly prespecified definition of their invasive reference tests, resulting in unprecedentedly informative results for this reference group. Data Collection and Analysis: From the 5,634 studies identified, 1,306 relevant articles were selected after title screening and further abstract screening left 865 studies for full-text review. Of these, 47 studies fulfilled all inclusion criteria resulting in a total sample size of 4,742 patients. Results: pCMR studies showed a superior sensitivity [0.88 (95% confidence interval (CI): 0.85–0.90) vs. 0.72 (95% CI: 0.61–0.81)], diagnostic odds ratio (DOR) [38 (95% CI: 29–49) vs. 20 (95% CI: 9–46)] and an augmented post-test probability [negative likelihood ratio (LR) of 0.14 (95% CI: 0.12–0.18) vs. 0.31 (95% CI: 0.21, 0.46)] as compared to DSE. Specificity was statistically indifferent [0.84 (95% CI: 0.81–0.87) vs. 0.89 (95% CI: 0.83–0.93)]. Conclusion: The results of this systematic review and meta-analysis suggest that pCMR has a superior diagnostic test accuracy for relevant CAD compared to DSE. In patients with intermediate risk of CAD only pCMR can reliably rule out relevant stenosis. In this risk cohort, pCMR can be offered for initial risk stratification and guidance of further invasive treatment as it also rules in relevant CAD.

Item Type:	Article
Official URL:	https://www.frontiersin.org/journals/cardiovascula...
Additional Information:	© 2021 The Author(s).
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RC Internal medicine
Date Deposited:	11 Aug 2022 15:45
Last Modified:	12 Dec 2024 03:12
URI:	http://eprints.lse.ac.uk/id/eprint/115973

Actions (login required)

View Item